Thrombolysis in acute myocardial infarction

G. Tognoni, C. Fresco, M. G. Franzosi, A. P. Maggioni

Research output: Contribution to journalArticlepeer-review


The 1980s has been a critical decade for the management of acute myocardial infarction (MI) because of the concentration in a very short time span of innovative results produced by a new generation of trials, in which thrombolysis has been the preeminent topic. The message coming from the results in the more than 50,000 patients included in the five key trials is simple and clear: thrombolysis, of any type, is the cornerstone of acute treatment of MI, and it works well to produce a very favorable epidemiologic picture. In the GISSI-2 trial, the nationwide adoption of a package of recommended treatments centered on thrombolysis for the overall population of patients with an acute MI has produced a relevant modification of the natural history of the disease, reducing the in-hospital mortality by about 40% in few years (from 13% to 8.8%). In particular, in the great majority of cases (patients aged

Original languageEnglish
Issue number4 SUPPL.
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Thrombolysis in acute myocardial infarction'. Together they form a unique fingerprint.

Cite this